Skip to main content
. 2004 Aug 9;32(14):4205–4216. doi: 10.1093/nar/gkh720

Table 1. Oligonucleotides used in this study.

Oligo Sequence
1 5′-CGA ACA ATT CAG CGG CTT TAA CCG GAC GCT CGA CGC CAT TAA TAA TGT TTT C-3′ (52)
2 5′-GAA AAC ATT ATT AAT GGC GTC GAG CTA GGC ACA AGG CGA ACT GCT AAC GG-3′ (50)
3 5′-TGG GCT CAC GTG GTC GAC GCT GGA GGT GAT CAC CAG ATG ATT GCT AGG CAT GCT TTC CGC AAG AGA ACG GGC GTC TGC GTA CCC GTG CAG-3′ (90)
4 5′-CTG CAC GGG TAC GCA GAC GCC-3′ (21)
5 5′-TTT TTT TTT TTT TTT TTT TTT TTT TCG GAC GCT CGA CGC CAT TAA TAA TGT TTT C-3′ (55)
6 5′-TGA AAA CAT TAT TAA TGG CGT CGA GCG TCC G-3′ (31)
7 5′-TGA AAA CAT TAT TAA TGG CGT CGA GCG TCC GTT TTT TTT TTT TTT TTT TTT TTT TT-3′ (56)
8 5′-CTG CAC GGG TAC GCA GAC GCC CGT TCT CTT-3′ (30)
9 5′-GAT CAC CTC CAG CGT CGA CCA CGT GAG CCC-3′ (30)
10 5′-CCG TTA GCA GTT CGC CTT GTG CCT A-3′ (25)
11 5′-CGA ACA ATT CAG CGG CTT TAA CCG GAC GCT CGA CGC CAT TAA TAA TGT TTT C-3′ (52)
12 5′-TTT TTT TTT TTT TTT TTT TTT CGG ACG CTC GAC GCC ATT AAT AAT GTT TTC-3′ (51)
13 5′-TTT TTT TTT TTT TTT TTT TTT CGG CTT TAA CCG GAC GCT CGA CGC CAT TAA TAA TGT TTT C-3′ (61)
14 5′-TTT TTT TTT TTT TTT TTT TTT CGA ACA ATT CAG CGG CTT TAA CCG GAC GCT CGA CGC CAT TAA TAA TGT TTT C-3′ (73)
15 5′-GCG CAT GTG CGT TCC ATT TGC CGA ACA ATT CAG CGG CTT TAA CCG GAC GCT CGA CGC CAT TAA TAA TGT TTT C-3′ (73)
16 5′-CTG CTG CTG CTG CTG CTG CTG CTG CTG CTG CTG CTG CTG CTG CTG CTG GCT CGA CGC CAT TAA TAA TGT TTT C-3′ (73)
17 5′-CTC CTC CTC CTC CTC CTC CTC CTC CTC CTC CTC CTC CTC CTC CTC CTC GCT CGA CGC CAT TAA TAA TGT TTT C-3′ (73)
18 5′-GCC TGC ACG TGG CGA TCG TT CGA TCG CCA CGT GCA GGC G CTG CTG CTG GCT CGA CGC CAT TAA TAA TGT TTT C-3′ (73)
19 5′-GCG GCC TGG CTG CTG CTG CTG CTG CTG CTG CTG CTG CTG CCA GGC CGC GCT CGA CGC CAT TAA TAA TGT TTT C-3′ (73)
20 5′-CAG CGT CGA CCA CGT GAG CCC-3′ (21)

The numbers in parentheses indicate the length of each oligonucleotide. Boldface indicates ribonucleotides.

HHS Vulnerability Disclosure